Dr. Lori Glimcher

Revolutionizing Cancer Treatment with Immunotherapy: Talks at GS Session Highlights

Giovanni Caforio, Laurie Glimcher, Jill O'Donnell-Tormey, Dr. Giovanni Coforio, Dr. Lori Glimcher, Jamie

Immunotherapy has emerged as a transformative cancer treatment by harnessing the patient's immune system to target mutated cells through checkpoint blockade, offering a personalized alternative to the non-specific toxicity of traditional chemotherapy. Clinical trials in melanoma and lung cancer have demonstrated that this approach yields response rates exceeding 60% and has nearly eliminated the need for first-line chemotherapy in these malignancies. Looking ahead, the field aims to expand these outcomes by addressing patient non-responsiveness through strategies that personalize therapy based on unique tumor genetic profiles.